PhD Nika Strašek Benedik

PhD Nika Strašek Benedik
no.: 52378 source: ARIS

researcher – active in research organisation
  nika.strasek.benedikat signffa.uni-lj.si
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
304.45
A''
38.64
A'
225.08
A1/2
255.78
CI10
142
CImax
45
h10
6
A1
1.16
A3
0
Data for the last 5 years (citations for the last 10 years) on March 26, 2026; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 17  150  128  7.53 
Scopus 17  162  139  8.18 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
2nd cycle master's degree  M. Sc.     SI University of Ljubljana, Faculty of Chemistry and Chemical Technology 2015 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2024 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (50%, RD:50%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  9/1/2018  Researcher  Researcher  Assistant 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. Z1-70012  Introducing PROTAKs: Evaluation of TAK1 chimeric degraders as a treatment option for rheumatoid arthritis   5/1/2027 - 4/30/2029  PhD Nika Strašek Benedik   45 
2. J1-60023  Boosting Our Resolve against Carbapenemase-Resistance with boron-containing therapeutics   1/1/2025 - 12/31/2027  PhD Alen Krajnc   2,318 
3. N1-0331  A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases   1/1/2024 - 12/31/2027  PhD Izidor Sosič   1,166 
4. J1-50037  Development of CDK1-selective degraders for the treatment of T-cell malignancies   10/1/2023 - 9/30/2026  PhD Izidor Sosič   1,361 
5. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   10/1/2022 - 9/30/2025  PhD Matej Sova   4,436 
6. J1-2484  Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis   9/1/2020 - 8/31/2023  PhD Stanislav Gobec   4,293 
7. J4-1778  Exploitation of a virus-borne small protein to combat antibiotic resistance in Staphylococcus aureus   7/1/2019 - 12/31/2022  PhD Matej Butala   3,745 
8. NC-0009  Development of new carbamate-based imaging probes for cholinesterases   4/1/2019 - 3/31/2021  PhD Stanislav Gobec   1,183 
9. L1-8157  Razvoj multifunkcionalnih učinkovin za zdravljenje Alzheimerjeve bolezni (Slovene)   5/1/2017 - 4/30/2020  PhD Stanislav Gobec   5,126 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2022 - 12/31/2027 PhD Stanislav Gobec   6,109 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2015 - 12/31/2021 PhD Stanislav Gobec   6,813 
Confirmation required
Views history
Favourite